Trial intelligence / Profile preview

Dextenza vs prednisolone in cataract surgery

NCT05023304Phase 4Completed

Sponsor
Vance Thompson Vision
Start
Aug 2021
Primary completion
Jul 2022
Modality
Implantable Devices, Implantable Hydrogels, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ozurdex in cataract, sponsored by Vance Thompson Vision. Started Aug 2021; status: completed.

02

Drugs

ozurdex
03

Conditions

cataract

Beyond the preview

Go deeper on NCT05023304.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05023304.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call